Effect of early revascularisation in cardiogenic shock complicating acute myocardial infarction. A single center experience

European Journal of Heart Failure

Volumn 5, Issue 1, 2003, Pages 73-79

  Lindholm, M G ^a   Aldershvile, J ^a   Sundgreen, C ^a   Jørgensen, Erik ^a   Saunamäki, Kari ^a   Boesgaard, S ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cardiogenic shock; Myocardial infarction; PTCA; Revascularisation

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CHRONOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; DENMARK; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; TIME; TIME FACTORS; TREATMENT OUTCOME;

EID: 0037272587     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(02)00112-5     Document Type: Article

References (25)

1. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999;340:1162-8.
2. Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of cardiogenic shock and effect of early revascularisation on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation 1995;91:873-81.
3. Goldberg RJ, Gore JM, Alpert JS, et al. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 1991;325:1117-22.
4. Holmes DRJ, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995;26:668-74.
5. Cohn JN, Tristani FE, Khatri IM. Cardiac and peripheral vascular effects of digitalis in clinical cardiogenic shock. Am Heart J 1969;78:318-30.
6. Loeb HS, Winslow EB, Rahimtoola SH, Rosen KM, Gunnar RM. Acute hemodynamic effects of dopamine in patients with shock. Circulation 1971;44:163-73.
7. Loeb HS, Rahimtoola SH, Gunnar RM. The failing myocardium. I. Drug management. Med Clin North Am 1973;57:167-85.
8. Wilcox RG, von der Lippe G. Olsson CG, et al. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of early Thrombolysis (ASSET). Lancet 1988;2:525-30.
9. The AIMS Study Group. APSAC Intervention Mortality Study. Lancet 1988;i:545-9.
10. Fibrinolytic Therapy Trialists (FIT). Collaborative group: Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity from all randomised trials of more than 1000 patients. Lancet 1995;343:311-22.
11. GISSI. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
12. Stone GW. Primary PTCA in high- risk patients with acute myocardial infarction. J Invasive Cardiol 1995;7 (suppl. F):12F-21F.
13. Kennedy JW, Gensini G, Timmis GC, Maynard CM. Acute myocardial infarction treated with intracoronary streptokinase: A report of the Society for Cardiac Angiography. Am J Cardiol 1985;55:871-7.
14. Hochmann JS, Gersh BJ. Acute myocardial infarction. In: Topol E, editor. Complications.Textbook of Cardiovascular Medicine. Philadelphia, USA: Lippincott-Raven Publishers, 1998. p. 437-80.
15. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularisation in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999;341:625-34.
16. Hasdai D, Holmes DRJ, Topol EJ, et al. Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries. Eur Heart J 1999;20:128-35.
17. Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol Sept. 2000;36 (3 Suppl. A):1123-9.
18. Bates ER, Stomel RJ, Hochman JS, Ohman EM. The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in cardiogenic shock. Int J Cardiol 1998;65(Suppl. 1):S37-42.
19. Ohman EM, Nanas J, Stoml R, et al. A prospective randomized trial of thromolysis and counterpulsation to improve cardiogenic shock survival. Preliminary results of the TACTICS trial. Eur Heart J 2000;21 (suppl):190 (abstract).
20. Antoniucci D, Valenti R, Santoro GM, et al. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol 1998;31:294-300.
21. Hasdai D, Harrington RA, Hochman JS, et al. Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent STsegment elevation. J Am Coll Cardiol 2000;36:685-92.
22. Williams SG, Wright DJ, Tan LB. Management of cardiogenic shock complicating acute myocardial infarction: towards evidence based medical practice. Heart 2000;83:621-6.
23. Urban P, Stauffer JC, Bleed D, et al. A randomized evaluation of early revascularisation to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur Heart J 1999;20:1030-8.
24. Hochman JS, Sleeper LA, White HD, et al. One-year survival following early revascularization for cardiogenic shock. JAMA 2001;10(285 (2)):190-2.
25. Brodie BR, Stuckey TD, Hansen C, Muncy D. Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol 1999;84:18-23.